Latest stories on IMCR
Stocktwits Pharma Pulse: Biotech Beats The Broader Market — Novo, Pfizer And Moderna Earnings Up Next
Stocktwits News58 · neutralearnings
Immunocore’s Tebentafusp Data Refresh: What the Updated Uveal Melanoma Trial Means for IMCR Investors
TipRanks58 · neutralproduct/pr
Immunocore doses first patient in IMC-S118AI trial
The Fly61 · neutralproduct/pr
Immunocore: Advanced Cutaneous Melanoma Data Catalysts Feel Crucial
Seeking Alpha73 · bullishproduct/pr
Immunocore Holdings plc (IMCR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
Immunocore Completes Enrollment in Phase 3 Melanoma Trial
TipRanks63 · neutralproduct/pr
Immunocore achieves target patient enrollment in TEBE-AM clinical trial
The Fly67 · bullishproduct/pr
Immunocore Holdings plc (IMCR) files 8-K
SEC 8-K50 · neutralgeneral
Immunocore to present at upcoming investor conferences
Business Insider56 · neutralgeneral
Immunocore to present at upcoming investor conferences
GlobeNewswire56 · neutralgeneral
Immunocore reinstated with an Overweight at JPMorgan
The Fly63 · neutralanalyst
Immunocore Price Target Raised To 43 From 40 At Morgan Stanley
The Fly61 · neutralanalyst
Immunocore Holdings plc 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Immunocore outlines TEBE-AM data as early as end of 2026 while scaling KIMMTRAK beyond ~1,000 patients per year
Seeking Alpha63 · neutralproduct/pr
Immunocore Holdings plc (IMCR) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Immunocore Q2 Earnings Call Highlights
Yahoo Finance65 · bullishearnings
Immunocore Holdings plc (IMCR) files 8-K
SEC 8-K50 · neutralgeneral
Immunocore reports second quarter financial results and provides a business update
Business Insider55 · neutralearnings